Pharmafile Logo
Pharmafocus logo
Advanced Search
janssen_latest_logo_on_sign_closer

Strong cancer trial data for Janssen at ASH 2015

December 8, 2015
Research and Development Cancer, Janssen, darzalex, imbruvica, oncology

Janssen presented new cancer trial data at the 57th Annual American Society of Haematology (ASH) meeting Orlando, Florida – with …

News
EMA inside

Sandoz announces biosimilar successes

December 8, 2015
Manufacturing and Production American Society of Hematology, Enbrel, Neulasta, Sandoz, ash, biosimilars, etanercept, pegfilgrastim

Novartis’ biosimilars division Sandoz has announced progress in its biosimilars programme, with its version of Amgen’s Neulasta proving as effective …

News
Lilly_labs_2

Lilly pulls plug on basal insulin Peglispro

December 8, 2015
Manufacturing and Production R&D, basal insulin peglispro, diabetes, lilly, peglispro, phase III failure

Lilly has decided to pull out of filing its diabetes drug basal insulin peglispro, after failing to convince regulators and …

News
Amgen scientist

Pharma companies ‘among happiest places to work’

December 8, 2015
Manufacturing and Production Jobs, careers, employee satisfaction, pharma jobs, recruitment

Five pharmaceutical companies have placed in a top 50 of the happiest companies in America listing, based on reviews by …

News
Ninlaro

Takeda’s Ninlaro extends myeloma survival in trial

December 7, 2015
Manufacturing and Production, Research and Development Ninlaro, Takeda, ash, ixazomib, multiple myeloma

Takeda has presented trial data showing that treatment with its oral proteasome inhibitor Ninlaro extended progression free survival by 35% …

News
Keytruda image

MSD’s Keytruda shows promise in multiple myeloma

December 7, 2015
Manufacturing and Production MSD, Revlimid, dexamethasone, keytruda, multiple myeloma, pembrolizumab

MSD has announced that it has initiated two Phase III studies based in part on the strength of early data, …

News
eczema_finger

Featured Market Report: Atopic Dermatitis (eczema) Forecast in 17 Major Markets

December 7, 2015
Manufacturing and Production, Research and Development Black Swan, eczema

Featured Market Report: Forecast Report on Atopic Dermatitis (eczema) in 17 Major Markets  Black Swan’s report on Atopic Dermatitis, also …

Feature
Pfizer CEO Ian Read

Five benefits and challenges of the Pfizer/Allergan mega-merger

December 7, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Pfizer, acquisitions, mergers, takeovers

Pfizer was extremely keen to get the $160 billion deal done, but what is it getting out of the acquisition, …

Feature
Merck image

Late-stage failure for Merck and Threshold cancer drug

December 7, 2015
Research and Development, Sales and Marketing Merck, Pancreatic cancer, Threshold Pharmaceuticals, evofosfamide, late-stage failure, phase III, sarcoma

Merck and its development partner Threshold Pharmaceuticals say they will not pursue regulatory approval for evofosfamide in advanced soft tissue …

News
Justice department

Mylan receives court summons from US Department of Justice

December 7, 2015
Sales and Marketing Drug pricing, Justice department, Mylan, US Department of Justice, generics, investigation, subpoena

The US Department of Justice has contacted Mylan to make enquiries about the company’s pricing structure for antibiotic, doxycycline. Mylan …

News

Takeda reveals five-year Adcetris survival data

December 6, 2015
Research and Development, Sales and Marketing Hodgkin lymphoma, Takeda, oncology

Takeda UK has announced post-treatment follow up data from the pivotal Phase II study of Adcetris revealing a five-year survival …

News
kyprolis_amgen

Amgen’s Kyprolis doubles Velcade benefit in head-to-head study

December 5, 2015
Research and Development, Sales and Marketing Amgen, Cancer, Kyprolis, Takeda, Velcade, multiple myeloma

Amgen has announced that its multiple myeloma therapy Kyprolis displayed superiority to Takeda’s Velcade in the Phase III ENDEAVOR study …

News
l-r_alg_ceo_hugh_sheridan_with_cfo_jackie_fisher_and_coo_matt_guixe_-_low_res

ALG makes senior hires to increase global growth

December 4, 2015
Manufacturing and Production, Sales and Marketing

Medical products company ALG has hired Matt Guixe as chief operating officer and Jackie Fisher as chief financial officer. Guixe …

Appointment
Neusentis

Pfizer to close UK R&D site in surprise move

December 4, 2015
Research and Development, Sales and Marketing Pfizer

Two weeks after its $160 billion buyout of botox-maker Allergan, Pfizer has announced that it is to close a UK …

News
Logos

New regulatory submissions for AbbVie and Novo Nordisk

December 4, 2015
Medical Communications AbbVie, EMA, FDA, Novo Nordisk, Viekira Pak, insulin aspart

AbbVie and Novo Nordisk have submitted new drug applications to the US FDA and European Medicines Agency (EMA) respectively. The …

News
john_harris

OBN appoints Dr John Harris as chief executive

December 4, 2015
Medical Communications, Sales and Marketing OBN

OBN, the membership organisation supporting the UK’s emerging life sciences companies, has appointed Dr John Harris as its new chief executive, replacing …

Appointment
Teva image

Teva strips $1 billion worth of assets to clear Allergan deal

December 4, 2015
Medical Communications, Sales and Marketing Allergan, Teva, acquisitions, divestments, mergers

Teva Pharmaceuticals is thought to be in the process of stripping nearly $1 billion worth of assets to address antitrust …

News
Novartis image

NICE backtracks on Novartis Farydak decision

December 4, 2015
Medical Communications, Sales and Marketing Farydak, NICE, Novartis, panobinostat

NICE has reversed its earlier decision to reject the Novartis drug Farydak as an NHS treatment for people with multiple …

News
zometa

Cancer drugs prices vary up to 388% between high-income countries

December 4, 2015
Medical Communications, Sales and Marketing Cancer, Drug pricing, Eli Lilly, Genzyme, Lancet, Novartis, oncology

The price of new cancer drugs varies widely between high-income countries in Europe, Australia, and New Zealand, new research published …

News
digital

Big Pharma taking steps towards fully digital businesses

December 3, 2015
Medical Communications Accenture, digital pharma, innovation

Pharma companies can tap into $100 billion of revenue from being ‘digital transformers’, and not just ‘digital followers’, a leading …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026